Why the study?
To explore the correlation between serum T cell replacing factor (TRF) and liver glutathione peroxidase 2 (LGP2) levels and cardiac function in patients with coronary heart disease.
Population
252 patients with CHD and 240 healthy controls
Comparison
Patients with CHD vs healthy controls
Design
Case-control study
Key result
Serum TRF and LGP2 levels were significantly lower in patients with coronary heart disease compared to healthy controls and correlated with worse cardiac function indicators (P<0.05).
Authors
Loading...
Lower TRF and LGP2 levels associate with CHD severity; hypothesis-generating, requiring prospective validation before clinical use.
Case-Control (n=492)
p-value: p=<0.05
Serum TRF and LGP2 levels are significantly decreased in patients with coronary heart disease and correlate strongly with worsening cardiac function and structural remodeling.
Cui et al. (2026) conducted a case-control in Coronary heart disease (n=492). Serum TRF and LGP2 levels vs. Healthy controls was evaluated on Correlation between serum TRF and LGP2 levels and cardiac function markers (p=<0.05). Serum TRF and LGP2 levels were significantly lower in patients with coronary heart disease compared to healthy controls and correlated with worse cardiac function indicators (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: